• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
LGP
Click for more information
5.71% 9.9¢

LITTLE GREEN PHARMA LTD - News & Media

Market Cap $29.87M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Little Green Pharma (ASX:LGP) is an Australia-based medicinal cannabis company with a... Little Green Pharma (ASX:LGP) is an Australia-based medicinal cannabis company with a track record of sales growth with a clear pathway to increasing margins and driving revenues.More

Recently Updated

Corporate Spotlight

Little Green Pharma (ASX:LGP) LGP is an Australia-based medicinal cannabis company with a track record of sales growth with a clear pathway to increasing margins and driving revenues.
View the full Corporate Spotlight arrow Created with Sketch.

LGP REPORTS REVENUE INCREASE IN Q4FY24

Articles & Videos

Little Green Pharma (ASX:LGP) reports revenue increase in Q4 FY24

This interview discusses Little Green Pharma’s (ASX:LGP) record-breaking quarterly results for June 2024, highlighting a 12% increase in revenue and significant cash receipts. CEO Paul Long elaborates on the company’s growth drivers, including new product sales in ...

3 days ago

Little Green Pharma's cannabis sales leap 30%

Little Green Pharma saw sales leap 30% to $25.6 million in the financial year to March 31 witjh flower sales soaring 72% in Australia.

31 May 2024 16:58 (AEST)

Little Green Pharma closely eyeing USA's legal downgrade of Cannabis danger

Overnight, the Biden government did something sure to give their counterparts a stir – the USA downgraded the risk profile it gives cannabis.

02 May 2024 10:06 (AEST)

Little Green Pharma heading into Q2 cashed up after record sales

Little Green Pharma (ASX:LGP) wound up Q1CY24 with $5M in cash after posting record sales of $8.1M, up 53% QoQ.

17 Apr 2024 11:57 (AEST)

Little Green Pharma shares surge as Germany legalises Cannabis

Little Green Pharma (ASX: LGP), has revealed a groundbreaking development with the German Bundestag's decision on Friday to legalise cannabis, removing it from the Narcotics List starting April 1, 2024

26 Feb 2024 11:45 (AEDT)

Reset Mind Sciences to remain Little Green Pharma subsidiary

Reset Mind Sciences has withdrawn its offers under the Prospectus lodged with ASIC on November 9, 2023, and will remain a subsidiary of Little Green Pharma (ASX:LGP).

19 Feb 2024 12:11 (AEDT)

Little Green Pharma receives $5m R&D rebate

Little Green Pharma (ASX:LGP) has received a $5 million research and development (R&D) rebate, its largest to date.

01 Feb 2024 11:26 (AEDT)

Little Green Pharma's Cherry Co brand flourishes after December launch

Little Green Pharma (ASX:LGP) has released its quarterly activities report for December 2023, reporting a 25 per cent increase in revenue to $18.1 million.

31 Jan 2024 14:41 (AEDT)

Little Green Pharma kicks off WA psychedelic mental health trial

Little Green Pharma (ASX:LGP) attached entity Reset Mind Sciences has kicked off a WA-based trial investigating the use of psilocybin.

11 Jan 2024 11:03 (AEDT)

Little Green Pharma positions itself for growth in France's emerging medicinal cannabis market

Little Green Pharma (ASX:LGP) is primed for substantial growth after a major amendment to the French health security bill, paving the way for medicinal cannabis' integration into the national healthcare system.

07 Dec 2023 10:59 (AEDT)



(20min delay)
Last
9.9¢ 		Change
-0.006(5.71%) 		Mkt cap ! $29.87M
Open High Low Value Volume
10.0¢ 10.0¢ 9.7¢ $2.21K 22.20K

Buyers (Bids)

No. Vol. Price($)
2 93495 9.7¢
 

Sellers (Offers)

Price($) Vol. No.
9.9¢ 2072 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
Last
9.9¢ 		  Change
-0.006 ( 5.71 %)
Open High Low Volume
10.0¢ 10.0¢ 9.7¢ 35610
Last updated 15.59pm 26/07/2024 ?
LGP (ASX) Chart

Top Stories

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

Nova Minerals (ASX:NVA) shares dipped nearly -3% in Friday morning trades after announcing it was closing the pre-listing IPO process for its new NASDAQ digs.The company is listing on the tech heavy stock market at a value of only US$3.3M @ firmly landing it in the nanocap end of things, Australi...
Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper? Monadelphous (ASX:MND) has flagged its receipt of a $200M contract with Woodside Energy (ASX:WDS).
ASX Market Open: ASX200 to rise for Friday session | July 26 The ASX200 is set to rise 0.4% according to ASX futures around 8.30am on the final day of the week.
Nine's staff strike as Paris Olympic coverage begins Paris is off to a rocky start, with Australia's beloved Matildas going down 3-0 to Germany overnight, five water polo stars being struck by Covid, and if that's not enough to dull the excitement, Nine Entertainment Co Holdings (ASX:NEC) sent reporters to Paris only to have some of its unionised team go on strike in a fight for better pay.
Tissue Repairs soars nearly 32% on TGA approval for wound healing gel Biotech company Tissue Repair Ltd (ASX:TRP) has seen its share price rise more than 30% on news it had gained TGA (Therapeutic Goods Administration) approval for its advanced wound healing gel TR Pro+, which contains yeast-derived active ingredient Glucoprime.At 13:25 AEDT, shares in Tissue Repai...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.